Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.68 |
| ▸ | TK1 | P04183 | 5/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ALB | P02768 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | TK2 | O00142 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL767324 | 1.00 | RNASE1 (0.68) | RNASE1TK1SLC6A2LMNATSHR | |
| SCHEMBL14681227 | 1.00 | RNASE1 (0.68) | RNASE1TK1SLC6A2LMNATSHR | |
| SCHEMBL16287348 | 1.00 | RNASE1 (0.68) | RNASE1TK1SLC6A2LMNATSHR | |
| SCHEMBL3337696 | 0.92 | RNASE1 (0.71) | RNASE1TK1SLC6A2LMNATSHR | |
| SCHEMBL19407973 | 0.92 | RNASE1 (0.71) | RNASE1TK1SLC6A2LMNATSHR | |
| SCHEMBL13901238 | 0.92 | RNASE1 (0.71) | RNASE1TK1SLC6A2LMNAALB | |
| SCHEMBL16349867 | 0.92 | RNASE1 (0.71) | RNASE1TK1SLC6A2LMNAALB | |
| SCHEMBL5180425 | 0.90 | ABCG2 (0.59) | RNASE1TK1 | |
| SCHEMBL4099261 | 0.89 | TK1 (0.61) | RNASE1TK1SLC6A2LMNATSHR | |
| SCHEMBL265601 | 0.89 | RNASE1 (0.74) | RNASE1TK1LMNATSHRALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10465242-B2 | Multi-sequence capture system | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2019-11-05 | — | — | US | disclosed |
| US-20180057874-A1 | MULTI-SEQUENCE CAPTURE SYSTEM | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2018-03-01 | — | — | US | disclosed |
| US-20180057874-A1 | MULTI-SEQUENCE CAPTURE SYSTEM | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2018-03-01 | — | — | US | disclosed |
| US-8889843-B2 | Nucleic acid synthesizing dimer amidite and nucleic acid synthesizing method | APTA BIOSCIENCES LTD. (GB) | 2014-11-18 | — | — | US | disclosed |
| US-20140179875-A1 | SULFURIZATION REAGENTS ON SOLID SUPPORTS | GIRINDUS AMERICA, INC. (US) | 2014-06-26 | — | — | US | disclosed |
| US-8710210-B2 | Method of using N-thio compounds for oligonucleotide synthesis | GIRINDUS AMERICA, INC. (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130096291-A1 | New Method of Using N-Thio Compounds for Oligonucleotide Synthesis | GIRINDUS AMERICA, INC. (US) | 2013-04-18 | — | — | US | disclosed |
| US-20120071640-A1 | Sulfurizing reagents and their use for oligonucleotides synthesis | GIRINDUS AMERICA, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| US-20120071640-A1 | Sulfurizing reagents and their use for oligonucleotides synthesis | GIRINDUS AMERICA, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| WO-2012001126-A1 | A NEW METHOD OF USING N-THIO COMPOUNDS FOR OLIGONUCLEOTIDE SYNTHESIS | GIRINDUS AMERICA, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071640-A1 | Sulfurizing reagents and their use for oligonucleotides synthesis | RRM1, SRRT, NSUN2 | RNASE1 456/4885TK1 679/4885SLC6A2 2957/4885 |
| US-20130096291-A1 | New Method of Using N-Thio Compounds for Oligonucleotide Synthesis | RNGTT, TST, NOP2 | RNASE1 369/4885TK1 43/4885SLC6A2 2667/4885 |
| US-20140179875-A1 | SULFURIZATION REAGENTS ON SOLID SUPPORTS | OR10J3, RPS8, NSUN2 | RNASE1 2182/4885TK1 2907/4885SLC6A2 4716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.